Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dupixent COPD Approval Could Be Delayed, Regeneron Cautions
May 02 2024
•
By
Jessica Merrill
Regeneron signaled a possible delay for Dupixent in COPD • Source: Shutterstock
More from Immunological
More from Therapy Areas